Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$151.05 - $180.26 $223,554 - $266,784
-1,480 Reduced 15.85%
7,860 $1.22 Million
Q3 2022

Nov 03, 2022

BUY
$161.33 - $179.52 $1,129 - $1,256
7 Added 0.08%
9,340 $1.53 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $4,204 - $4,650
25 Added 0.27%
9,333 $1.66 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $146,753 - $166,659
928 Added 11.07%
9,308 $1.65 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $15,593 - $17,301
-100 Reduced 1.18%
8,380 $1.43 Million
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $1.62 Million - $1.8 Million
-10,010 Reduced 54.14%
8,480 $1.37 Million
Q1 2021

May 06, 2021

SELL
$153.07 - $170.48 $2.55 Million - $2.84 Million
-16,653 Reduced 47.39%
18,490 $3.04 Million
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $4.82 Million - $5.53 Million
35,143 New
35,143 $5.53 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Decatur Capital Management, Inc. Portfolio

Follow Decatur Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Decatur Capital Management, Inc. with notifications on news.